How much funding has Cellino raised?

Cellino has raised $121.0M in total funding, most recently a Grant round.

Who are Cellino's investors?

Cellino's investors include Khosla Ventures, The Engine, ARPA-H, Leaps by Bayer, Felicis Ventures, Humboldt Fund.

Where is Cellino headquartered?

Cellino is headquartered in Cambridge, Massachusetts, United States.

What industry is Cellino in?

Cellino operates in Biotech, Healthcare, Nanotechnology.

Cellino

Your Cells, Your Cure

Cambridge, United States · Founded 2017 · $121.0M raised

Biotech

Healthcare

Nanotechnology

Headquarters: Cambridge, Massachusetts
Employees: 51–200
Founded: 2017
Business Model: B2B

Website: cellinobio.com
Total Funding: $121.0M
Last Round: $25.0M GrantSep 2024
Rounds: 3

About

Cellino is building an ultra-scalable biomanufacturing technology stack for personalized regenerative medicines using AI-guided laser editing and automation. The company's platform enables autologous iPSC-derived cell therapies to scale from research to clinical and commercial production, targeting degenerative diseases with a 'Your Cells, Your Cure' approach.

Summary

Cellino is a Biotech company based in Cambridge, United States, founded in 2017. It has raised $121.0M in total across 3 rounds, most recently a $25.0M Grant round in Sep 2024. Investors include Khosla Ventures, The Engine and ARPA-H.

LinkedIn X (Twitter)